Literature DB >> 29886367

Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada.

Benedikt Fischer1, Thepikaa Varatharajan2, Kevin Shield3, Jürgen Rehm4, Wayne Jones5.   

Abstract

BACKGROUND: Numerous interventions aimed at addressing the Canadian 'opioid crisis' have been implemented. However, no empirical estimaes of the number of people with problematic prescription opioid (PO) use exist to inform and guide intervention system needs.
METHODS: The annual numbers of Canadian adults (≥ 15 years) with PO misuse and/or use disorders ('addiction') were estimated by combining data on the prevalence and associated 95% Confidence Intervals (CIs) of PO use in the Canadian population, obtained from national surveys, with PO misuse and use disorders transition probabilities, obtained from high-quality studies in recent meta-analyses. Uncertainty Intervals (UI) were estimated using Monte Carlo simulations.
RESULTS: Population estimates of PO use were highest in 2008, with 5,967,046 (95% CI: 5,635,543-6,326,173) people using POs (representing 21.6% of adults), and lowest in 2015, with 3,941,935 (95% CI: 3,580,842-4,272,937) people using POs (13.1%). Furthermore, PO misuse and use disorders were highest in 2008, with 1,408,223 (95% UI: 878,686-1,951,211; 5.1% of adults) and 525,100 (95% UI 258,288-801,472; 1.9%) people with PO misuse and use disorders respectively. These numbers declined to 930,297 (95% UI: 576,083-1,295,310; 3.1% of adults) and 346,890 (95% UI: 168,310-532,941; 1.2%) people with PO misuse and use disorders, respectively, in 2015.
CONCLUSION: While seemingly declining over-time, the crude population estimates for problematic PO use were high, likely outweighing current intervention capacities. Furthermore, these estimates do not account for the delay of onset and duration of PO misuse and disorders. Thus, more rigorous problem population estimates should be generated to guide interventions.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Canada; Misuse; Opioid use disorder; Population; Prescription opioids; Prevalence

Mesh:

Substances:

Year:  2018        PMID: 29886367     DOI: 10.1016/j.drugalcdep.2018.04.024

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

1.  Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.

Authors:  Benedikt Fischer; Michelle Pang; Mark Tyndall
Journal:  J Public Health (Oxf)       Date:  2020-11-23       Impact factor: 2.341

2.  What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size.

Authors:  Katherine M Keyes; Caroline Rutherford; Ava Hamilton; Joshua A Barocas; Kitty H Gelberg; Peter P Mueller; Daniel J Feaster; Nabila El-Bassel; Magdalena Cerdá
Journal:  Drug Alcohol Depend Rep       Date:  2022-04-08

3.  Estimating the Prevalence of Opioid use Disorder in the Cincinnati Region using Probabilistic Multiplier Methods and Model Averaging.

Authors:  Peter J Mallow; Nila Sathe; Michael Topmiller; Jennifer Chubinski; Dillon Carr; Roni Christopher
Journal:  J Health Econ Outcomes Res       Date:  2019-04-03

4.  The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada.

Authors:  M Eugenia Socias; Cameron Grant; Kanna Hayashi; Geoff Bardwell; Mary Clare Kennedy; M-J Milloy; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2021-09-25       Impact factor: 4.492

5.  Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.

Authors:  Benedikt Fischer; Wayne Jones; Mark Tyndall; Paul Kurdyak
Journal:  BMC Public Health       Date:  2020-01-31       Impact factor: 3.295

6.  'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America.

Authors:  Benedikt Fischer; Caroline O'Keefe-Markman; Angelica Min-Hye Lee; Dimitri Daldegan-Bueno
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-15

7.  Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study.

Authors:  Isabel Hurtado; Aníbal García-Sempere; Salvador Peiró; Gabriel Sanfélix-Gimeno
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

8.  'Safer opioid distribution' as an essential public health intervention for the opioid mortality crisis - Considerations, options and examples towards broad-based implementation.

Authors:  Benedikt Fischer; Angelica Lee; Lenka Vojtila
Journal:  Public Health Pract (Oxf)       Date:  2020-05-26

9.  The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis?

Authors:  Benedikt Fischer; Michelle Pang; Wayne Jones
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-02-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.